You can buy or sell Smith & Nephew and other stocks, options, ETFs, and crypto commission-free!
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. Read More It operates through the United Kingdom, United States of America, and Other geographical segments. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.
52 Week High
52 Week Low
Advertising and Marketing
Yahoo FinanceMay 22
Smith & Nephew's OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020
LONDON, May 22, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Annual Meeting in New Orleans.
Yahoo FinanceMay 14
How Good Is Smith & Nephew plc, When It Comes To ROE?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Smith & Nephew plc (LON:SN.). Scroll to continue with content Ad Over the last twelve months Smith & Neph...
Available Jul 31, Pre-Market